Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder Tumor.
Uleri A, Contieri R, Moretto S, Cieri M, Paciotti M, Hurle R, Fasulo V, Arena P, Massimo L, Avolio P, Mallia V, Buffi N, Colombo P, Lughezzani G. Uleri A, et al. Among authors: paciotti m. Eur Urol Open Sci. 2024 Sep 17;69:71-72. doi: 10.1016/j.euros.2024.08.016. eCollection 2024 Nov. Eur Urol Open Sci. 2024. PMID: 39329072 Free PMC article. No abstract available.
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study.
Casale P, Saita A, Lazzeri M, Lughezzani G, Hurle R, Fasulo V, Mondellini GM, Paciotti M, Domanico L, Lista G, Maffei D, Monari M, Motta L, Bini V, Ceriotti F, Guazzoni G, Buffi NM. Casale P, et al. Among authors: paciotti m. Minerva Urol Nefrol. 2019 Jun;71(3):273-279. doi: 10.23736/S0393-2249.19.03279-X. Epub 2019 Jan 28. Minerva Urol Nefrol. 2019. PMID: 30700081 Free article.
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: pure versus non-pure CIS.
Hurle R, Lazzeri M, Saita A, Naselli A, Guarneri A, Buffi NM, Lughezzani G, Fasulo V, Mondellini GM, Paciotti M, Domanico L, Peschechera R, Benetti A, Zandegiacomo S, Lista G, Pasini L, Guazzoni G, Casale P. Hurle R, et al. Among authors: paciotti m. Minerva Urol Nefrol. 2019 Aug;71(4):406-412. doi: 10.23736/S0393-2249.19.03254-5. Epub 2019 May 28. Minerva Urol Nefrol. 2019. PMID: 31144485 Free article.
Comparison of the Diagnostic Accuracy of Micro-ultrasound and Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies for the Diagnosis of Clinically Significant Prostate Cancer.
Lughezzani G, Saita A, Lazzeri M, Paciotti M, Maffei D, Lista G, Hurle R, Buffi NM, Guazzoni G, Casale P. Lughezzani G, et al. Among authors: paciotti m. Eur Urol Oncol. 2019 May;2(3):329-332. doi: 10.1016/j.euo.2018.10.001. Epub 2018 Oct 25. Eur Urol Oncol. 2019. PMID: 31200848
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project.
Hurle R, Casale P, Saita A, Colombo P, Elefante GM, Lughezzani G, Fasulo V, Paciotti M, Domanico L, Bevilacqua G, Maffei D, Diana P, Frego N, Sandri MT, Maura F, Morenghi E, Buffi NM, Guazzoni G, Lazzeri M. Hurle R, et al. Among authors: paciotti m. World J Urol. 2020 Sep;38(9):2215-2220. doi: 10.1007/s00345-019-03002-3. Epub 2019 Nov 5. World J Urol. 2020. PMID: 31691083
Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study.
Lughezzani G, Maffei D, Saita A, Paciotti M, Diana P, Buffi NM, Colombo P, Elefante GM, Hurle R, Lazzeri M, Guazzoni G, Casale P. Lughezzani G, et al. Among authors: paciotti m. Eur Urol Focus. 2021 Sep;7(5):1019-1026. doi: 10.1016/j.euf.2020.09.013. Epub 2020 Oct 15. Eur Urol Focus. 2021. PMID: 33069624
116 results